Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000366417 | SCV000341122 | uncertain significance | not provided | 2016-04-20 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000350950 | SCV000410023 | uncertain significance | Bone Paget disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000390248 | SCV000410024 | uncertain significance | Osteopetrosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764168 | SCV000895170 | uncertain significance | Paget disease of bone 2, early-onset; Familial expansile osteolysis; Autosomal recessive osteopetrosis 7 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000366417 | SCV002451843 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000366417 | SCV004143226 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | TNFRSF11A: BS2 |
Prevention |
RCV003940032 | SCV004754566 | benign | TNFRSF11A-related disorder | 2022-10-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |